Wick Capital Partners’s Merck MRK Stock Holding History

Wick Capital Partners’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,553	Closed	-$269K	–	248
2025 Q4	$269K	Buy	+2,553	New	+$240K	0.05%	159

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wick Capital Partners's MRK Position: Q1 2026 in Review

Wick Capital Partners sold out of Merck (MRK) in Q1 2026, closing a stake of 2,553 shares — an estimated $269K sold.

Wick Capital Partners first reported a position in MRK in Q4 2025 and held it in 1 quarter. The position peaked at $269K in Q4 2025. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Wick Capital Partners reported no remaining Merck position as of Q1 2026 after selling out during the quarter.
Wick Capital Partners sold 2,553 Merck shares in Q1 2026, an estimated $269K.
Wick Capital Partners first reported a position in Merck in Q4 2025 and held it in 1 quarter.
Wick Capital Partners's Merck position peaked at $269K in Q4 2025.
3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Wick Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.